Cough: are children really different to adults?

Anne B Chang1

  • 1Dept of Respiratory Medicine, Royal Children's Hospital, Brisbane, Queensland 4029, Australia. annechang@ausdoctors.net

Cough (London, England)
|November 8, 2005
PubMed

Insights

Pediatric cough management differs significantly from adults. Key causes and effective treatments for children

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Physiology
  • Clinical Pharmacology

Background:

  • Paediatricians emphasize distinct management approaches for children versus adults.
  • The cough pathway is intrinsically linked to the maturation of the central respiratory pattern generator.
  • Developmental stages in respiratory control suggest corresponding developmental changes in cough mechanisms.

Purpose of the Study:

  • To delineate similarities and differences in cough between children and adults.
  • To compare the etiological factors of chronic cough in pediatric and adult populations.
  • To evaluate the therapeutic strategies for cough in children versus adults.

Main Methods:

  • Review of physiological links between cough and respiratory control.
  • Clinical and epidemiological comparison of chronic cough causes in adults and children.
  • Analysis of therapeutic efficacy and safety of common cough medications in pediatric populations.

Main Results:

  • The 'big three' causes of chronic cough in adults (asthma, post-nasal drip, gastroesophageal reflux) are less prevalent in children.
  • Empirical treatments for adult cough, such as antihistamines, codeine, and corticosteroids, show limited efficacy and potential toxicity in children.
  • Paediatric cough has distinct etiological factors and requires different treatment protocols compared to adult cough.

Conclusions:

  • Management guidelines for paediatric cough must differ from adult guidelines.
  • Etiological factors for cough in children are significantly different from those in adults.
  • Therapeutic interventions for paediatric cough require specialized consideration due to differing efficacy and safety profiles.

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...